EP Patent

EP2834241A4 — POLYMORPHIC FORMS OF -2- (1- (9H-PURIN-6-YLAMINO) PROPYL) -5-FLUORO-3-PHENYLQUINAZOLIN-4 (3H) -ONE ACID

Assigned to Gilead Calistoga LLC · Expires 2015-11-11 · 11y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: EP2834241A4
Jurisdiction: EP
Classification: —
Expires: 2015-11-11
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Calistoga LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.